Howdy dangerman......the ease of administration of immunerotherapy and the relative
costs make it a highly commercial entity....Consequently it is far more affordable than
previous treatments.......
CVAC for example.......one day in hospital to get the blood, put into a refridgerated container, taken
to the Airport for shipment to Germany, delivered to Lab, treated(2weeks) back in the fridge,
back in the plane, back to Aust., back to hospital to administer to patient....Expensive.....
Lag 3 products....3-4 hrs in hospital for treatment.....done....
Make no mistake the market is only interested in money....Lag-3 is where it's at....
CNBC - Immunotherpay Kite Pharma CEO, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |